EverSource Wealth Advisors’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.1K Sell
843
-103
-11% -$2.36K ﹤0.01% 2456
2026
Q1
$22K Sell
946
-6
-0.6% -$129 ﹤0.01% 2444
2025
Q4
$19K Sell
952
-761
-44% -$14.9K ﹤0.01% 2418
2025
Q3
$31.3K Sell
1,713
-685
-29% -$13.4K ﹤0.01% 2031
2025
Q2
$48.2K Buy
2,398
+1,795
+298% +$34.5K ﹤0.01% 1640
2025
Q1
$10.9K Sell
603
-25
-4% -$448 ﹤0.01% 2065
2024
Q4
$10.9K Buy
628
+54
+9% +$1.04K ﹤0.01% 1945
2024
Q3
$11.1K Hold
574
﹤0.01% 1804
2024
Q2
$10.8K Hold
574
﹤0.01% 1810
2024
Q1
$8.67K Hold
574
﹤0.01% 1768
2023
Q4
$9.21K Hold
574
﹤0.01% 1586
2023
Q3
$7.46K Sell
574
-103
-15% -$1.34K ﹤0.01% 1531
2023
Q2
$8.62K Sell
677
-897
-57% -$11.2K ﹤0.01% 1502
2023
Q1
$17.7K Buy
1,574
+1,461
+1,293% +$17.7K ﹤0.01% 1125
2022
Q4
$1.5K Hold
113
﹤0.01% 1992
2022
Q3
$1K Hold
113
﹤0.01% 1834
2022
Q2
$2K Hold
113
﹤0.01% 1517
2022
Q1
$2K Hold
113
﹤0.01% 1533
2021
Q4
$2K Buy
+113
New +$1.93K ﹤0.01% 1564

Other funds holding INVA

EverSource Wealth Advisors's INVA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Innoviva (INVA) stake by 11% in Q2 2026, selling an estimated $2.36K and leaving 843 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

EverSource Wealth Advisors first reported a position in INVA in Q4 2021 and has held it in 19 quarters since. The position peaked at $48.2K in Q2 2025. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • EverSource Wealth Advisors held 843 shares of Innoviva worth $19.1K as of Q2 2026.
  • EverSource Wealth Advisors sold 103 Innoviva shares in Q2 2026, an estimated $2.36K.
  • Innoviva made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2456 holding.
  • EverSource Wealth Advisors first reported a position in Innoviva in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Innoviva position peaked at $48.2K in Q2 2025.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.